Previous 10 | Next 10 |
First Solar Inc. (FSLR) is expected to report $3.19 for Q4 2023 VIZIO Holding Corp. Class A (VZIO) is expected to report $0.02 for Q4 2023 Henry Schein Inc. (HSIC) is expected to report $0.71 for Q4 2023 Republic Services Inc. (RSG) is expected to report $1.28 for Q4 2023 Forge Gl...
2024-02-25 08:00:00 ET The last week of February promises a dynamic mix of earnings reports across various sectors. In the technology space, investors are eagerly anticipating updates from Salesforce ( NYSE: CRM ), Snowflake ( NYSE: SNOW ), Zoom Video Communications ( NASD...
2024-02-21 05:30:54 ET Summary Masimo's core segment in Professional Healthcare could have support into a multi-year growth based on current growth of Unrecognized Contract Value growth. Expansion into the consumer space is a logical extension to leverage its core tech and segment...
Masimo (NASDAQ: MASI), a leading global provider of medical technology and automation solutions, and UCHealth , a nationally recognized network of hospitals, clinics, and providers based in Colorado, announced today that they are entering into a strategic collaboration to improve the standa...
2024-02-20 08:00:00 ET Summary Masimo's favorable court ruling against Apple has boosted its shares and market share projections. In my view, the ongoing legal battle tarnishes Apple's image, while Masimo claims superiority in pulse oximetry technology. ActLight's DPD technolo...
2024-02-18 09:59:03 ET Summary Masimo Corp is set to report its full-year earnings, with expectations for a slight decline in adjusted EPS. The company's financials show manageable debt and a decent current ratio, but declining margins and profitability. The acquisition of Sou...
Masimo MightySat ® Medical Provides Clinically Proven Masimo SET ® Pulse Oximetry to Consumers for Medical Use Without a Prescription Masimo (NASDAQ: MASI) announced today FDA clearance of MightySat ® Medical, making it the first and only FDA-cleared medic...
Masimo (NASDAQ: MASI) today announced the findings of a retrospective, peer-reviewed study published in the Journal of Clinical Monitoring and Computing in which Dr. Vikrant Sharma, along with Dr. Steven J. Barker, Dr. William C. Wilson, and colleagues at Masimo performed a focused analysis...
2024-01-30 14:54:41 ET More on Masimo Masimo: Lots Of Moving Parts Masimo Corporation (MASI) Q3 2023 Earnings Call Transcript Masimo Corporation 2023 Q3 - Results - Earnings Call Presentation Masimo appoints Bob Chapek to Board of Directors Apple to d...
2024-01-24 07:35:00 ET Summary Ensemble Capital Management builds focused investment portfolios to help you preserve your success and enhance your future. Serving clients with assets ranging from about $3 million to $250+ million, Ensemble offers a high level of personalized service t...
News, Short Squeeze, Breakout and More Instantly...
Politan Will Take All Necessary Action to Ensure That the Annual Meeting Is Not Delayed Any Further Beyond September 19 and Hopefully Is Held Sooner Politan Capital Management (together with its affiliates, “Politan”), an 8.9% shareholder of Masimo Corporation (“Mas...
Masimo Corporation (“Masimo” or the “Company”) (Nasdaq: MASI), a global leader in noninvasive monitoring technologies and audio products, today announced that it has commenced litigation against Politan Capital Management LP (“Politan”) in federal court i...
To ensure that Politan lies repeated over and over are not taken as fact, Masimo Corporation (“Masimo” or the “Company”) (NASDAQ: MASI) sets forth below facts in response to what we believe are some of Politan’s and Quentin Koffey’s most egregious and con...